Literature DB >> 7587299

Early changes in matrix metalloproteinases and inhibitors after in vitro laser treatment to the trabecular meshwork.

D E Parshley1, J M Bradley, J R Samples, E M Van Buskirk, T S Acott.   

Abstract

Extracellular matrix turnover in the trabecular meshwork may play a role in regulating aqueous humor outflow. Laser trabeculoplasty is a common treatment for open-angle glaucoma. The mechanism of this treatment is not understood. We investigated changes in the levels and expression of the matrix metalloproteinases and their tissue inhibitors (TIMPs) in this tissue using cultured human anterior segment explants and standard clinical-parameter laser treatment. Medium gelatinase A activity levels are relatively high for sham-treated controls and are not changed dramatically following laser treatment. Medium gelatinase B and stromelysin activity levels are low in sham-treated explants and increase significantly by 24 h after treatment. TIMP1 levels, as assessed by immunoblots of Western transfers, are initially low. However, by 24 h TIMP1 levels have increased significantly. Using semi-quantitative reverse transcription and the polymerase chain reaction, mRNA levels of stromelysin, gelatinase B and TIMP1 are shown to increase after laser treatment, while gelatinase A and TIMP2 remain relatively constant. The increases in trabecular stromelysin and gelatinase B in response to laser trabeculoplasty may have important implications for the mechanism of action of this treatment for open-angle glaucoma.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7587299     DOI: 10.3109/02713689508998400

Source DB:  PubMed          Journal:  Curr Eye Res        ISSN: 0271-3683            Impact factor:   2.424


  18 in total

Review 1.  Extracellular matrix in the trabecular meshwork.

Authors:  Ted S Acott; Mary J Kelley
Journal:  Exp Eye Res       Date:  2008-01-25       Impact factor: 3.467

2.  Effect of previous argon laser trabeculoplasty on the ocular hypotensive action of latanoprost.

Authors:  Esther Arranz-Marquez; Miguel A Teus
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2006-01-14       Impact factor: 3.117

3.  Impact of laser pulse duration on the reduction of intraocular pressure during selective laser trabeculoplasty.

Authors:  Spela Stunf Pukl; Brigita Drnovšek-Olup
Journal:  Int Ophthalmol       Date:  2016-12-31       Impact factor: 2.031

4.  Expression of gelatinase B in trachomatous conjunctivitis.

Authors:  A M El-Asrar; K Geboes; S A Al-Kharashi; A A Al-Mosallam; L Missotten; L Paemen; G Opdenakker
Journal:  Br J Ophthalmol       Date:  2000-01       Impact factor: 4.638

Review 5.  Effects of prostaglandin analogues on aqueous humor outflow pathways.

Authors:  Nelson S Winkler; Michael P Fautsch
Journal:  J Ocul Pharmacol Ther       Date:  2013-12-20       Impact factor: 2.671

6.  Matrix metalloproteinase (MMP-2, -9) and tissue inhibitor (TIMP-1, -2) activity in tear samples of pediatric type 1 diabetic patients: MMPs in tear samples from type 1 diabetes.

Authors:  Chrysanthos Symeonidis; Eleni Papakonstantinou; Asimina Galli; Ioannis Tsinopoulos; Asimina Mataftsi; Spyridon Batzios; Stavros A Dimitrakos
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-12-20       Impact factor: 3.117

Review 7.  Prospects for genetic intervention in primary open-angle glaucoma.

Authors:  M K Wirtz; T S Acott; J R Samples; J C Morrison
Journal:  Drugs Aging       Date:  1998-11       Impact factor: 3.923

Review 8.  The many faces of the trabecular meshwork cell.

Authors:  W Daniel Stamer; Abbot F Clark
Journal:  Exp Eye Res       Date:  2016-07-19       Impact factor: 3.467

Review 9.  Stress response of the trabecular meshwork.

Authors:  Paloma B Liton; Pedro Gonzalez
Journal:  J Glaucoma       Date:  2008-08       Impact factor: 2.503

10.  [Pattern laser trabeculoplasty and argon laser trabeculoplasty for treatment of glaucoma].

Authors:  C E Barbu; W Rasche; P Wiedemann; J Dawczynski; J D Unterlauft
Journal:  Ophthalmologe       Date:  2014-10       Impact factor: 1.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.